In a post-hoc analysis of SURPASS-CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/tirzepatide-shows-key-kidney-benefits-over-dulaglutide-2025a1000v9q?src=rss
Author :
Publish date : 2025-11-11 19:12:00
Copyright for syndicated content belongs to the linked Source.
